Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/05 (2006.01)

Patent

CA 2266098

N-L-.alpha.-Aspartyl-L-phenylalanine 1-methyl ester (APM) and its derivatives have been found to effect disease regression in osteoarthritis, osteoporosis, and rheumatoid arthritis. APM performs as a TNF-.alpha. antagonist as well as an antipyretic agent.

L'invention concerne la découverte que le N-L-.alpha.-Aspartyl-L-phénylalanine 1-méthyl ester (APM) et ses dérivés provoquent la régression de maladies telles que l'arthrose, l'ostéoporose et la polyarthrite. L'APM agit en tant qu'antagoniste de TNF-.alpha. ainsi que comme agent antipyrétique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1612345

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.